1. Home
  2. GHRS vs KRNT Comparison

GHRS vs KRNT Comparison

Compare GHRS & KRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • KRNT
  • Stock Information
  • Founded
  • GHRS 2018
  • KRNT 2002
  • Country
  • GHRS Ireland
  • KRNT Israel
  • Employees
  • GHRS N/A
  • KRNT N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • KRNT Industrial Machinery/Components
  • Sector
  • GHRS Health Care
  • KRNT Industrials
  • Exchange
  • GHRS Nasdaq
  • KRNT Nasdaq
  • Market Cap
  • GHRS 737.5M
  • KRNT 875.0M
  • IPO Year
  • GHRS 2021
  • KRNT 2015
  • Fundamental
  • Price
  • GHRS $14.76
  • KRNT $19.99
  • Analyst Decision
  • GHRS Strong Buy
  • KRNT Strong Buy
  • Analyst Count
  • GHRS 8
  • KRNT 5
  • Target Price
  • GHRS $30.63
  • KRNT $33.20
  • AVG Volume (30 Days)
  • GHRS 204.8K
  • KRNT 276.3K
  • Earning Date
  • GHRS 05-08-2025
  • KRNT 08-06-2025
  • Dividend Yield
  • GHRS N/A
  • KRNT N/A
  • EPS Growth
  • GHRS N/A
  • KRNT N/A
  • EPS
  • GHRS N/A
  • KRNT N/A
  • Revenue
  • GHRS N/A
  • KRNT $206,506,000.00
  • Revenue This Year
  • GHRS N/A
  • KRNT $10.86
  • Revenue Next Year
  • GHRS N/A
  • KRNT $12.68
  • P/E Ratio
  • GHRS N/A
  • KRNT N/A
  • Revenue Growth
  • GHRS N/A
  • KRNT N/A
  • 52 Week Low
  • GHRS $6.00
  • KRNT $13.59
  • 52 Week High
  • GHRS $20.50
  • KRNT $34.29
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 66.16
  • KRNT 47.55
  • Support Level
  • GHRS $11.82
  • KRNT $19.40
  • Resistance Level
  • GHRS $12.94
  • KRNT $20.29
  • Average True Range (ATR)
  • GHRS 0.99
  • KRNT 0.80
  • MACD
  • GHRS 0.19
  • KRNT -0.01
  • Stochastic Oscillator
  • GHRS 84.53
  • KRNT 71.18

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About KRNT Kornit Digital Ltd.

Kornit Digital Ltd develops, designs and markets digital printing solutions for the world-wide printed textile industry. The company focuses on its DTG and DTF segments of the printed textile industry. Its solutions include digital printing systems, ink and other consumables, associated software and value-added services that allow for large-scale printing of short runs of complex images and designs directly on finished garments and fabrics. It generates revenue from sales of systems, ink and other consumables and service including software subscriptions The company geographically operates in U.S., EMEA, Asia Pacific and other countries. It derives maximum revenue from U.S.

Share on Social Networks: